Carolyn Anderson

Adjunct Professor


Ling, X., Latoche, J.D., Choy, C.J., Kurland, B.F., Laymon, C.M., Wu, Y., Salamacha, N., Shen, D., Geruntho, J.J., Rigatti, L.H., Windish, H.P., Langton-Webster, B., Berkman, C.E., & Anderson, C.J. (2020). Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403. MOLECULAR IMAGING AND BIOLOGY, 22(2), 274-284.Springer Science and Business Media LLC. doi: 10.1007/s11307-019-01404-8.

Patel, S.K., Beaino, W., Anderson, C.J., & Janjic, J.M. (2015). Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. CLINICAL IMMUNOLOGY, 160(1), 59-70.Elsevier BV. doi: 10.1016/j.clim.2015.04.019.

Soodgupta, D., Hurchla, M.A., Jiang, M., Zheleznyak, A., Weilbaecher, K.N., Anderson, C.J., Tomasson, M.H., & Shokeen, M. (2013). Very Late Antigen-4 (alpha(4)beta(1) Integrin) Targeted PET Imaging of Multiple Myeloma. PLOS ONE, 8(2), e55841.Public Library of Science (PLoS). doi: 10.1371/journal.pone.0055841.